BDX Becton, Dickinson and Company
Becton, Dickinson and Company (BDX) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is $4.06 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +4.3% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Becton, Dickinson and Company
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.
Sector
Healthcare
Industry
Medical Instruments/Supply